Comparison of Immunohystochemical (IHC) Expression Profile and Prognosis in 98 Patients with Diffuse Large B Cell Non-Hodgkin’s Lymphoma (DLBCL) with and without Human Immunodeficiency Virus (HIV) Infection.
Blanca Xicoy(Hospital Universitari Germans Trias i Pujol), Evarist Feliú(Universitat Autònoma de Barcelona), José Luís Mate(Universitat Autònoma de Barcelona), José‐Tomás Navarro(Universitat Autònoma de Barcelona), Mireia Morgades(Josep Carreras Leukaemia Research Institute), Gustavo Tapia(Hospital Universitari Germans Trias i Pujol), Josep‐María Ribera(Universitat Autònoma de Barcelona), Aurelio Ariza(Universitat Autònoma de Barcelona), Tatiana Ruíz(Hospital Universitari Germans Trias i Pujol)
Cited by 0
Related Papers
Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study
|The Lancet Oncology|2014|1.3k
Acute lymphoblastic leukaemia in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2016|457
Dasatinib and low-intensity chemotherapy in elderly patients with Philadelphia chromosome–positive ALL
|Blood|2016|329
Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia
|New England Journal of Medicine|2022|309